| Name | Title | Contact Details |
|---|---|---|
David Hansen |
President and Chief Executive Officer | Profile |
CG Therapeutics Inc is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OpGen, Inc. is a leading innovator in rapid, accurate genomic and DNA analysis systems and services.
A2 is dedicated to pushing the boundaries of science to transform medicine and turn the tide on cancer. We are focused on the next frontier in cell therapy: solid tumors.
NewLeaf Symbiotics® is at the forefront of sustainable agriculture technology, with a singular focus on the identification, development and commercialization of the beneficial microbes called pink pigmented facultative methylotrophs (M-trophs). This new class of agricultural microbes is helping transition agricultural products and production to deliver better quality crops, with less impact on the environment — a win-win for growers and those of us who depend on their success.
IMS Group is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.